6
114 Biostatistiques pour le clinicien
Références
1. Com-Nougue C, Rodary C (1987) Revue des procédures statistiques pour
mettre en évidence l’équivalence de deux traitements. Rev Epidem Santé Publi
35: 416-30
2. Weswstlake W (1972) Use of confidence intervals in analysis of comparative
biovailability trials. J Pharm Sci 61: 1340-1
3. Dunnett CW, Gent M (1977) Significance testing to establish equivalence
between treatments with special reference to date in form of 2 x 2 tables.
Biometrics 33: 593-602
4. Mandallaz D, Mau J (1981) Comparison of different methods for decisionmaking in bioequivalence assessment. Biometrics 37: 213-322
5. Hauck WW, Anderson S (1984) A new statistical procedure for testing
equivalence in two-groups comparative biovailability trials. J Pharmacokin
Biopharmaceut 12: 83-91
6. Patel HJ, Gupta GD (1981 March) A problem of equivalence in clinical trials.
Eastern North American Region meeting. Richmond Virginia
7. Karnofski DA, Abelmann WH, Craver LF, Burchenal JH (1948) The use of
nitrogen mustards in the palliative treatment of carcinoma. With particular
reference to brochongenic carcinoma. Cancer 1: 634-56